{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:59:52Z","timestamp":1780912792274,"version":"3.54.1"},"reference-count":9,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"DOI":"10.1111\/jdv.70515","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:01:37Z","timestamp":1780909297000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimized management of enfortumab vedotin\u2010related dermatological toxicity"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8563-1788","authenticated-orcid":false,"given":"Estelle","family":"Parriel","sequence":"first","affiliation":[{"name":"Oncodermatology, Univ Toulouse, Oncopole Claudius Regaud, IUCT\u2010Oncopole, CRCT  Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Perego\u2010Langlais","sequence":"additional","affiliation":[{"name":"Oncology Unit, Henri Mondor Hospital, APHP  Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-7096","authenticated-orcid":false,"given":"Saskia","family":"Ingen\u2010Housz\u2010Oro","sequence":"additional","affiliation":[{"name":"Dermatology Department, Henri Mondor Hospital, APHP, Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL  Cr\u00e9teil France"},{"name":"Epilogy (Epidemiology in Dermatology and Evaluation of Therapeutics), IMRB, INSERM, Univ Paris\u2010Est Cr\u00e9teil  Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2585-6633","authenticated-orcid":false,"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[{"name":"Oncodermatology, Univ Toulouse, Oncopole Claudius Regaud, IUCT\u2010Oncopole, CRCT  Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJMoa2035807","article-title":"Enfortumab vedotin in previously treated advanced urothelial carcinoma","volume":"384","author":"Powles T","year":"2021","journal-title":"N Engl J Med"},{"key":"e_1_2_2_3_1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles T","year":"2024","journal-title":"N Engl J Med"},{"key":"e_1_2_2_4_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejca.2022.02.019","article-title":"Life\u2010threatening skin reaction with enfortumab vedotin: six cases","volume":"167","author":"Guerrois F","year":"2022","journal-title":"Eur J Cancer"},{"key":"e_1_2_2_5_1","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1093\/oncolo\/oyac170","article-title":"Regarding \u201cmanagement of dermatologic events associated with the nectin\u20104\u2010directed antibody\u2010drug conjugate enfortumab vedotin\u201d","volume":"27","author":"Ingen\u2010Housz\u2010Oro S","year":"2022","journal-title":"Oncologist"},{"key":"e_1_2_2_6_1","first-page":"e99","article-title":"Skin toxicity of enfortumab vedotin: proposal of a specific management algorithm","volume":"38","author":"Ingen\u2010Housz\u2010Oro S","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_2_7_1","first-page":"1","article-title":"Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment","volume":"00","author":"Oya K","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_2_8_1","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1093\/oncolo\/oyac001","article-title":"Management of dermatologic events associated with the nectin\u20104\u2010directed antibody\u2010drug conjugate enfortumab vedotin","volume":"27","author":"Lacouture ME","year":"2022","journal-title":"Oncologist"},{"key":"e_1_2_2_9_1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/cup.14689","article-title":"Enfortumab vedotin\u2010induced cutaneous eruption: ring mitotic figures as a distinctive histopathologic feature","volume":"51","author":"Sport C","year":"2024","journal-title":"J Cutan Pathol"},{"key":"e_1_2_2_10_1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/DAD.0000000000002750","article-title":"Enfortumab Vedotin drug eruption: cutaneous adverse events and histopathologic findings","volume":"46","author":"Casale F","year":"2024","journal-title":"Am J Dermatopathol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.70515","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.70515","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:01:39Z","timestamp":1780909299000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.70515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":9,"alternative-id":["10.1111\/jdv.70515"],"URL":"https:\/\/doi.org\/10.1111\/jdv.70515","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"2026-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdv.70515"}}